Top

FOR TRANSLATIONAL RESEARCH IN NUCLEAR MEDICINE.

Arronax Nantes brings together all stakeholders in Nantes working on research and development in nuclear medicine.

This more particularly include the GIP ARRONAX, the laboratories CeisamCEMA-OnirisCRCINA, LS2NSubatech, the CRIP-Oniris core facility and the Nuclear Medicine departments of the University Hospital of Nantes and the ICO.

Arronax Nantes is a stakeholder in the I-SITE NExT, in close collaboration with the LabEx IRON and the SIRIC ILIAD.

our publications

  • Overview of the Most Promising Radionuclides for Targeted Alpha Therapy: The “Hopeful Eight”, Eychenne R, Chérel M, Haddad F, Guérard F, Gestin J-F., Pharmaceutics. 18 juin 2021;13(6):906. https://doi.org/10.3390/pharmaceutics13060906
  • A Monte Carlo Determination of Dose and Range Uncertainties for Preclinical Studies with a Proton Beam, Bongrand A, Koumeir C, Villoing D, Guertin A, Haddad F, Métivier V, et al., Cancers. 15 avr 2021;13(8):1889. https://doi.org/10.3390/cancers13081889

our news

Our equipments